[1]杨宁,贺涛,邢怡桥.半乳糖凝集素与眼部新生血管形成[J].眼科新进展,2017,37(1):083-86.[doi:10.13389/j.cnki.rao.2017.0023]
　YANG Ning,HE Tao,XING Yi-Qiao.Galectin and ocular angiogenesis[J].Recent Advances in Ophthalmology,2017,37(1):083-86.[doi:10.13389/j.cnki.rao.2017.0023]
点击复制

半乳糖凝集素与眼部新生血管形成/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年1期
页码:
083-86
栏目:
文献综述
出版日期:
2017-01-05

文章信息/Info

Title:
Galectin and ocular angiogenesis
作者:
杨宁; 贺涛; 邢怡桥
430071 湖北省武汉市，武汉大学人民医院眼科中心
Author(s):
YANG Ning; HE Tao; XING Yi-Qiao
Eye Center，Renmin Hospital of Wuhan University，Wuhan 430071，Hubei Province，China
关键词:
半乳糖凝集素; 新生血管; 内皮细胞
Keywords:
galectin; angiogenesis; endothelial cell
分类号:
R744.1
DOI:
10.13389/j.cnki.rao.2017.0023
文献标志码:
A
摘要:
多种眼部组织都可能形成新生血管，如角膜、虹膜、视网膜和脉络膜等。而病理性新生血管的产生是导致视力损害甚至致盲的重要原因之一，如增生型糖尿病视网膜病变和年龄相关性黄斑变性等。半乳糖凝集素（Galectin）作为凝集素超家族中的一个家族，在人和动物的许多组织中广泛分布。近来许多研究都表明半乳糖凝集素家族参与了细胞黏附、细胞凋亡、炎症反应和肿瘤转移等生理和病理过程，其在肿瘤新生血管中的作用也越来越受到重视，而糖基化也是哺乳动物蛋白转录后修饰的重要方式之一。本文就半乳糖凝集素在眼部新生血管中的作用进行综述。
Abstract:
Numerous of ocular diseases are related to angiogenesis,including neovascularization of cornea,iris,retina and choroid.Pathological angiogenesis is a leading cause of visual impairment and blindness,such as proliferative diabetic retinopathy and age-related macular degeneration.Galectins are extensively distributed and expressed in tissues of human and animal.Recent investigations indicated that galectins were involved in the modulation of cell adhesion,cell apoptosis,inflammation and tumor metastasis.Glycosylation is also a significant mode of transcriptional modification in mammals.This article reviews the relationship between galectins and angiogenesis,especially ocular neovascularization.

参考文献/References:

［1］　COPPINI LP，VISNIAUSKAS B，COSTA EF，FILHO MN，ROD-RIGUES EB，CHAGAS JR，et al.Corneal angiogenesis modulation by cysteine cathepsins:In vitro and in vivo studies［J］.Exp Eye Res，2015，134(1):39-46.
［2］　SOOHOO JR，SEIBOLD LK，PANTCHEVA MB，KAHOOK MY.Aflibercept for the treatment of neovascular glaucoma［J］.Clin Exp Ophthalmol，2015，43(9):803-807.
［3］　CAMPOCHIARO PA.Molecular pathogenesis of retinal and choroidal vascular diseases［J］.Prog Retin Eye Res，2015，49（1）:67-81.
［4］　MARKOWSKA AI，CAO Z，PANJWANI N.Glycobiology of ocular angiogenesis［J］.Glycobiology，2014，24(12):1275-1282.
［5］　DORRELL M，UUSITALO-JARVINEN H，AGUILAR E，FRIEDLANDER M.Ocular neovascularization:basic mechanisms and therapeutic advances［J］.Surv Ophthalmol，2007，52 Suppl (1):S3-19.
［6］　ISAAC M，MIRESKANDARI K，TEHRANI N.Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser［J］.J AAPOS， 2015，19(2):140-144.
［7］　TAN MH，MCALLISTER IL，GILLIES ME，VERMA N，BANERJEE G，SMITHIES LA，et al.Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion［J］.Am J Ophthalmol，2014，157(1):237-247.
［8］　SARWAR S，CLEARFIEL DE，SOLIMAN MK，SADIQ MA，BAL-DWIN AJ，HANOUT M，et al.Aflibercept for neovascular age-related macular degeneration［J］.Cochrane Database Syst Rev，2016，2:CD011346.
［9］　KANDA A，NODA K，SAITO W，ISHIDA S.Aflibercept traps galectin-1，an angiogenic factor associated with diabetic retinopathy［J］.Sci Rep，2015，5:17946.
［10］　CROCI D O，CERLIANI JP，DALOTTO-MORENO T，MENDEZ-HUERGO SP，MASCANFRONI ID，DERGAN-DYLON S，et al.Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors［J］.Cell，2014，156(4):744-758.
［11］　CAMBY I，LE MERCIER M，LEFRANC F，KISS R.Galectin-1:a small protein with major functions［J］.Glycobiology，2006，16(11):137-157.
［12］　HSIEH SH，YING NW，WU MH，CHIANG WF，HSU CL，WONG TY，et al.Galectin-1，a novel ligand of neuropilin-1，activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells［J］.Oncogene，2008，27(26):3746-3753.
［13］　TANG D，GAO J，WANG S，YE N，CHONG Y，HUANG Y，et al.Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression［J］.Tumour Biol，2016，37(2):1889-1899.
［14］　GRIFFIOEN AW，MOLEMA G.Angiogenesis:potentials for phar-macologic intervention in the treatment of cancer，cardiovascular diseases，and chronic inflammation［J］.Pharmacol Rev，2000，52(2):237-268.
［15］　THIJSSEN VL，HULSMANS S，GRIFFIOEN AW.The galectin profile of the endothelium:altered expression and localization in activated and tumor endothelial cells［J］.Am J Pathol，2008，172(2):545-553.
［16］　GRIFFIOEN AW，THIJSSEN VL.Galectins in tumor angiogenesis［J］.Ann Transl Med，2014，2(9):90.
［17］　THIJSSEN VL，RABINOVICH GA，GRIFFIOEN AW.Vascular galectins:regulators of tumor progression and targets for cancer therapy［J］.Cytokine Growth Factor Rev，2013，24(6):547-58.
［18］　COMPAGNO D，GENTILINI LD，JAWORSKI M，PEREZ IG，CONTRUFO G，LADERACH DJ.Glycans and galectins in prostate cancer biology，angiogenesis and metastasis［J］.Glycobiology，2014，24(10):899-906.
［19］　CARLINI MJ，ROITMAN P，NUNEZ M，PALLOTTA MG，BOGGIO G，SMITH D，et al.Clinical relevance of galectin-1 expression in non-small cell lung cancer patients［J］.Lung Cancer，2014，84(1):73-78.
［20］　OSE R，OHARAA O，NAGASE T.Galectin-1 and galectin-3 mediate protocadherin-24-dependent membrane localization of beta-catenin in colon cancer cell line HCT116［J］.Curr Chem Genomics，2012，6（1）:18-26.
［21］　ZHANG H，LUO M，LIANG X，WANG D，GU X，DUAN C，et al.Galectin-3 as a marker and potential therapeutic target in breast cancer［J］.PLoS One，2014，9(9):e103482.
［22］　SAUSSEZ S，DECAESTECKER C，MAHILLON V，CLUDTS S，CAPOUILLEZ A，CHEVALIER D，et al.Galectin-3 upregulation during tumor progression in head and neck cancer［J］.Laryngoscope，2008，118(9):1583-1590.
［23］　CAMBY I，BELOT N，RORIVE S，LEFRANC F，MAURAGE CA，LAHM H，et al.Galectins are differentially expressed in supratentorial pilocytic astrocytomas，astrocytomas，anaplastic astrocytomas and glioblastomas，and significantly modulate tumor astrocyte migration［J］.Brain Pathol，2001，11(1):12-26.
［24］　HEUSSCHEN R，SCHULKENS IA，VAN BEIJNUM J，GRIFFIOEN AW，THIJSSEN VL.Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis［J］.Biochim Biophys Acta，2014，1842(2):284-292.
［25］　PUNT S，THIJSSEN VL，VROLIJK J，DE KROON CD，GORTER A，JORDANOVA ES.Galectin-1，-3 and -9 expression and clinical significance in squamous cervical cancer［J］.PLoS One，2015，10(6):e0129119.
［26］　COMPAGNO D，JAWORSKI FM，GENTILINI L，CONTRUFO G，GONZALEZ-PEREZ I，ELOLA MT，et al.Galectins:major signaling modulators inside and outside the cell［J］.Curr Mol Med，2014，14(5):630-651.
［27］　D’HAENE N，SAUVAGE S，MARIS C，ADANJA I，LE MERCIER M，DECAESTECKER C，et al.VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis［J］.PLoS One，2013，8(6):e67029.
［28］　MARKOWSKA AI，LIU FT，PANJWANI N.Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response［J］.J Exp Med，2010，207(9):1981-1993.
［29］　MARKOWSKA AI，JEFFERIES KC，PANJWANI N.Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells［J］.J Biol Chem，2011，286(34):29913-29921.
［30］　THIJSSEN VL，BARKAN B，SHOJI H，ARIES IM，MATHIEU V，DELTOUR L，et al.Tumor cells secrete galectin-1 to enhance endothelial cell activity［J］.Cancer Res，2010，70(15):6216-6224.
［31］　THIJSSEN VL，POSTEL R，BRANDWIJK RJ，DINGS RP，NESMELOVA I，SATIJN S，et al.Galectin-1 is essential in tumor angiogenesis and is a target for antian giogenesis therapy［J］.Proc Natl Acad Sci USA，2006，103(43):15975-15980.
［32］　CROCI D O，SALATINO M，RUBINSTEIN N，CERLIANI JP，CAVALLIN L E，LEUNG HJ，et al.Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma［J］.J Exp Med，2012，209(11):1985-2000.
［33］　NANGIA-MAKKER P，HOGAN V，HONJO Y，BACCARINI S，TAIT L，BRESALIER R，et al.Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin［J］.J Natl Cancer Inst，2002，94(24):1854-1862.
［34］　NANGIA-MAKKER P，WANG Y，RAZ T，TAIT L，BALAN V，HOGAN V，et al.Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer［J］.Int J Cancer，2010，127(11):2530-2541.
［35］　DELGADO VM，NUGNES LG，COLOMBO LL，TRONCOSO MF，FERNANDEZ MM，MALCHIODI EL，et al.Modulation of endothelial cell migration and angiogenesis:a novel function for the “tandem-repeat” lectin galectin-8［J］.FASEB J，2011，25(1):242-254.
［36］　TRONCOSO MF，FERRAGUT F，BACIGALUPO ML，CARDENAS-DELGADO VM，NUGNES LG，GENTILINI L，et al.Galectin-8:a matricellular lectin with key roles in angiogenesis［J］.Glycobiology，2014，24(10):907-914.
［37］　MATHIEU V，DE LASSALLE EM，TOELEN J，MOHR T，BELLAHCENE A，VAN-GOIETSENOVEN G，et al.Galectin-1 in melanoma biology and related neo-angiogenesis processes［J］.J Invest Dermatol，2012，132(9):2245-2254.
［38］　WU MH，YING NW，HONG TM，CHIANG WF，LIN YT，CHEN YL.Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex［J］.Angiogenesis，2014，17(4):839-849.
［39］　ASTORGUES-XERRI L，RIVEIRO ME，TIJERAS-RABALLAND A，SEROVA M，RABINOVICH GA，BIECHE I，et al.OTX008，a selective small-molecule inhibitor of galectin-1，downregulates cancer cell proliferation，invasion and tumour angiogenesis［J］.Eur J Cancer，2014，50(14):2463-2477.
［40］　CANNING P，GLENN JV，HSU DK，LIU FT，GARDINER TA，STITT AW.Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes［J］.Exp Diabetes Res，2007，2007:51837.
［41］　NANGIA M，SYED W，DORAISWAMY PM.Efficacy and safety of St.John’s wort for the treatment of major depression［J］.Public Health Nutr，2000，3(4A):487-494.
［42］　SHAKIBA Y，MANSOURI K，ARSHADI D，REZAEI N.Corneal neovascularization:molecular events and therapeutic options［J］.Recent Pat Inflamm Allergy Drug Discov，2009，3(3):221-231.
［43］　CHEN WS，CAO Z，TRUONG L，SUGAYA S，PANJWANI N.Fingerprinting of galectins in normal，P.aeruginosa-infected，and chemically burned mouse corneas［J］.Invest Ophthalmol Vis Sci，2015，56(1):515-525.
［44］　FUKUSHI J，MAKAGIANSAR IT，STALLCUP WB.NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin［J］.Mol Biol Cell，2004，15(8):3580-3590.

相似文献/References:

[1]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[2]江新利 赵平 刘岩.PEDF在眼部疾病中的研究进展[J].眼科新进展,2013,33(5):000.
[3]赫雪飞 刘高勤 陈志刚 周文娟 肖艳辉 陆培荣.CCR3拮抗剂对视网膜血管内皮细胞管腔形成的影响及机制[J].眼科新进展,2013,33(12):000.
[4]赵 伟 蒋爱华 刘祖国.角膜碱烧伤后VEGF与新生血管渗漏性的相关性实验研究[J].眼科新进展,2009,29(1):000.
[5]田丽丽 任兵 高晓唯 罗英 蔡岩 周琨 杜安杰. 玻璃体内注射索拉非尼对大鼠氧诱导视网膜病变模型新生血管的作用[J].眼科新进展,2014,34(2):140.
[6]吴伟,李朝阳,王智崇,等.小牛血去蛋白提取物与重组人表皮生长因子促进兔角膜上皮损伤愈合和血管新生[J].眼科新进展,2014,34(5):401.[doi:10.13389/j.cnki.rao.2014.0111]
　WU Wei,LI Chao-Yang,WANG Zhi-Chong,et al.Effects of protein-free calf blood extract and recombinant human epithelial growth factor on mechanical corneal epithelial wound healing and neovascularization of rabbits[J].Recent Advances in Ophthalmology,2014,34(1):401.[doi:10.13389/j.cnki.rao.2014.0111]
[7]邹晶,喻理,许博涵,等. 肝素结合性表皮生长因子在翼状胬肉中的表达及意义[J].眼科新进展,2015,35(3):214.[doi:10.13389/j.cnki.rao.2015.0058]
　ZOU Jing,YU Li,XU Bo-Han,et al. Expression of HB-EGF in human pterygium and its significance[J].Recent Advances in Ophthalmology,2015,35(1):214.[doi:10.13389/j.cnki.rao.2015.0058]
[8]徐文芹,王雨生.赖氨酰氧化酶家族影响脉络膜新生血管生成的机制[J].眼科新进展,2016,36(1):081.[doi:10.13389/j.cnki.rao.2016.0023]
　XU Wen-Qin,WANG Yu-Sheng.Effects and mechanism of lysyl oxidase family in choroidal neovascularization[J].Recent Advances in Ophthalmology,2016,36(1):081.[doi:10.13389/j.cnki.rao.2016.0023]
[9]刘冬乐,张阳阳,高华.神经营养因子促进角膜上皮损伤修复的研究进展[J].眼科新进展,2017,37(5):492.[doi:10.13389/j.cnki.rao.2017.0125]
　LIU Dong-Le,ZHANG Yang-Yang,GAO Hua.Recent advances in neurotrophic factors promoting corneal epithelial wound healing[J].Recent Advances in Ophthalmology,2017,37(1):492.[doi:10.13389/j.cnki.rao.2017.0125]
[10]尹妮,赵帅,朱红娜.康柏西普预处理联合玻璃体切割术治疗增生型糖尿病视网膜病变[J].眼科新进展,2017,37(8):770.[doi:10.13389/j.cnki.rao.2017.0195]
　YIN Ni,ZHAO Shuai,ZHU Hong-Na.Conbercept pre-treatment combined with vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(1):770.[doi:10.13389/j.cnki.rao.2017.0195]

备注/Memo

备注/Memo:
国家自然科学基金资助(编号：81271025)
更新日期/Last Update: 2017-02-15